Empirical Modeling for Glucose Control in Critical Care and Diabetes
暂无分享,去创建一个
[1] Wei Jiang,et al. On-line outlier detection and data cleaning , 2004, Comput. Chem. Eng..
[2] Francis J. Doyle,et al. The identification of nonlinear models for process control using tailored “plant-friendly” input sequences , 2001 .
[3] Robert D. Nowak,et al. Random and pseudorandom inputs for Volterra filter identification , 1994, IEEE Trans. Signal Process..
[4] J. Jaremko,et al. Advances Toward the Implantable Artificial Pancreas for Treatment of Diabetes , 1998, Diabetes Care.
[5] Robert S. Parker,et al. A NONLINEAR DATA-DRIVEN APPROACH TO TYPE I DIABETIC PATIENT MODELING , 2002 .
[6] Francis J. Doyle,et al. Glucose control design using nonlinearity assessment techniques , 2005 .
[7] E. Zafiriou,et al. Output Constraint Softening for SISO Model Predictive Control , 1993, 1993 American Control Conference.
[8] Miet Schetz,et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.
[9] J. Radziuk,et al. An adaptive plasma glucose controller based on a nonlinear insulin/glucose model , 1994, IEEE Transactions on Biomedical Engineering.
[10] G. Steil,et al. Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis. , 2003, Diabetes technology & therapeutics.
[11] M. Schetzen. The Volterra and Wiener Theories of Nonlinear Systems , 1980 .
[12] H. Kaufman,et al. Multiple-model adaptive predictive control of mean arterial pressure and cardiac output , 1992, IEEE Transactions on Biomedical Engineering.
[13] M. Fisher,et al. A semiclosed-loop algorithm for the control of blood glucose levels in diabetics , 1991, IEEE Transactions on Biomedical Engineering.
[14] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[15] R.S. Parker,et al. A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.
[16] Ronald K. Pearson,et al. Nonlinear model-based control using second-order Volterra models , 1995, Autom..
[17] Julie L. Eiseman,et al. Toward Model-Based Chemotherapy Treatment Design , 2004 .
[18] R. Wolfe,et al. Glucose metabolism in man: responses to intravenous glucose infusion. , 1979, Metabolism: clinical and experimental.
[19] W. Schenk,et al. Does Physiological Blood Glucose Control Require an Adaptive Control Strategy? , 1987, IEEE Transactions on Biomedical Engineering.
[20] W Kerner,et al. Implantable glucose sensors: present status and future developments. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[21] G Albrecht,et al. Estimation of individually adapted control parameters for an artificial beta cell. , 1984, Biomedica biochimica acta.
[22] R. Wolfe,et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. , 1987, The New England journal of medicine.
[23] Evanghelos Zafiriou,et al. Robust process control , 1987 .
[24] Robert S. Parker,et al. Advanced model predictive control (MPC) for type I diabetic patient blood glucose control , 2000, Proceedings of the 2000 American Control Conference. ACC (IEEE Cat. No.00CH36334).
[25] R. Wolfe,et al. Differentiation between septic and postburn insulin resistance. , 1989, Metabolism: clinical and experimental.
[26] R. Bellazzi,et al. The subcutaneous route to insulin-dependent diabetes therapy. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.
[27] B.W. Bequette,et al. Model predictive control of blood glucose in type I diabetics using subcutaneous glucose measurements , 2002, Proceedings of the 2002 American Control Conference (IEEE Cat. No.CH37301).
[28] W. Rugh. Nonlinear System Theory: The Volterra / Wiener Approach , 1981 .
[29] G. Steil,et al. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. , 2003, Diabetes technology & therapeutics.
[30] R. Potts,et al. Glucose monitoring by reverse iontophoresis , 2002, Diabetes/metabolism research and reviews.
[31] H Wedel,et al. Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .
[32] Timothy W. Evans,et al. Glucose Control and Mortality in Critically Ill Patients , 2003 .
[33] B. Wayne Bequette,et al. Simultaneous Regulation of Hemodynamic and Anesthetic States: A Simulation Study , 2004, Annals of Biomedical Engineering.
[34] Francis J. Doyle,et al. Optimal control of a continuous bioreactor using an empirical nonlinear model , 2001 .
[35] R. Busch,et al. Accuracy of home blood glucose monitors using forearm blood samples: FreeStyle versus One Touch Ultra. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[36] Francis J. Doyle,et al. Robust H∞ glucose control in diabetes using a physiological model , 2000 .
[37] David Q. Mayne,et al. Constrained model predictive control: Stability and optimality , 2000, Autom..
[38] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[39] Gabriele Pannocchia,et al. A Fast, Easily Tuned, SISO, Model Predictive Controller , 2004 .
[40] R S Parker,et al. The intravenous route to blood glucose control. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.
[41] G. Grunkemeier,et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.
[42] R S Parker,et al. Control-relevant modeling in drug delivery. , 2001, Advanced drug delivery reviews.
[43] G. Dumont,et al. An optimum time scale for discrete Laguerre network , 1993, IEEE Trans. Autom. Control..
[44] Alberto Maran,et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. , 2002, Diabetes care.
[45] Robert S. Parker,et al. Glucose Control in Type I Diabetic Patients: A Volterra Model-Based Approach , 2004 .
[46] John Thomas Sorensen,et al. A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes , 1985 .
[47] R. Ollerton. Application of optimal control theory to diabetes mellitus , 1989 .
[48] E. Zafiriou,et al. Nonlinear system identification for control using Volterra-Laguerre expansion , 1995, Proceedings of 1995 American Control Conference - ACC'95.
[49] Francis J. Doyle,et al. Nonlinear model predictive control of a continuous bioreactor at near-optimum conditions , 1998, Proceedings of the 1998 American Control Conference. ACC (IEEE Cat. No.98CH36207).
[50] Sirish L. Shah,et al. Long-range predictive control with a terminal matching condition , 1994 .
[51] D.S. Ward,et al. Open loop control of multiple drug effects in anesthesia , 1995, IEEE Transactions on Biomedical Engineering.
[52] A Caduff,et al. First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. , 2003, Biosensors & bioelectronics.
[53] D. Kerr,et al. Making ‘sense’ of diabetes: using a continuous glucose sensor in clinical practice , 2002, Diabetes/metabolism research and reviews.
[54] Ronald K. Pearson,et al. Identification of structurally constrained second-order Volterra models , 1996, IEEE Trans. Signal Process..
[55] Manfred Morari,et al. Model predictive control: Theory and practice - A survey , 1989, Autom..
[56] E D Lehmann,et al. A physiological model of glucose-insulin interaction in type 1 diabetes mellitus. , 1992, Journal of biomedical engineering.